BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 8,126 shares, an increase of 156.0% from the June 15th total of 3,174 shares. Based on an average daily volume of 16,334 shares, the short-interest ratio is currently 0.5 days.
BioSyent Stock Up 0.2%
Shares of BIOYF stock opened at $10.40 on Thursday. BioSyent has a 52-week low of $7.63 and a 52-week high of $12.00. The company has a 50-day simple moving average of $10.16 and a two-hundred day simple moving average of $10.33.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
See Also
- Five stocks we like better than BioSyent
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
